BusinessRaptor Announces Qualified Infectious Disease Product (QIDP) Designation for MP-376, Inhaled LevofloxacinBy Nasdaq OMXMar 16, 2016, 11:30 AM UTC
BusinessRaptor Pharmaceutical to Participate in the Cowen and Company 36th Annual Health Care ConferenceBy Nasdaq OMXMar 1, 2016, 12:30 PM UTC